Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

Torre, 2015, Global Cancer Statistics, 2012, CA Cancer J Clin, 65, 87, 10.3322/caac.21262 Al Olama, 2014, A meta-analysis of 87 040 individuals identifies 23 new susceptibility loci for prostate cancer, Nat Genet, 46, 1103, 10.1038/ng.3094 Szulkin, 2015, Genome-wide association study of prostate cancer-specific survival, Cancer Epidemiol Biomarkers Prev, 24, 1796, 10.1158/1055-9965.EPI-15-0543 Xu, 2013, Prostate cancer risk-associated genetic markers and their potential clinical utility, Asian J Androl, 15, 314, 10.1038/aja.2013.42 Sigurdsson, 1997, BRCA2 mutation in Icelandic prostate cancer patients, J Mol Med (Berl), 75, 758, 10.1007/s001090050162 Johannsson, 1999, Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers, Eur J Cancer, 35, 1248, 10.1016/S0959-8049(99)00135-5 1999, Cancer risks in BRCA2 mutation carriers, J Natl Cancer Inst, 91, 1310, 10.1093/jnci/91.15.1310 Liede, 2004, Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature, J Clin Oncol, 22, 735, 10.1200/JCO.2004.05.055 Hart, 2016, Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer, BMJ Open, 6, e010332, 10.1136/bmjopen-2015-010332 Akbari, 2014, The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer, Br J Cancer, 111, 1238, 10.1038/bjc.2014.428 Castro, 2015, Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localized prostate cancer, Eur Urol, 68, 186, 10.1016/j.eururo.2014.10.022 Castro, 2013, Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer, J Clin Oncol, 31, 1748, 10.1200/JCO.2012.43.1882 Edwards, 2010, Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis, Br J Cancer, 103, 918, 10.1038/sj.bjc.6605822 Gallagher, 2010, Germline BRCA mutations denote a clinicopathologic subset of prostate cancer, Clin Cancer Res, 16, 2115, 10.1158/1078-0432.CCR-09-2871 Maier, 2014, Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations, Prostate, 74, 1444, 10.1002/pros.22860 Mitra a, 2008, Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype, Br J Cancer, 98, 502, 10.1038/sj.bjc.6604132 Narod, 2008, Rapid progression of prostate cancer in men with a BRCA2 mutation, Br J Cancer, 99, 371, 10.1038/sj.bjc.6604453 Tryggvadóttir, 2007, Prostate cancer progression and survival in BRCA2 mutation carriers, J Natl Cancer Inst, 99, 929, 10.1093/jnci/djm005 Risbridger, 2015, Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis, Eur Urol, 67, 496, 10.1016/j.eururo.2014.08.007 Kote-Jarai, 2011, BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients, Br J Cancer, 105, 1230, 10.1038/bjc.2011.383 Edwards, 2003, Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene, Am J Hum Genet, 72, 1, 10.1086/345310 Agalliu, 2007, Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer, Clin Cancer Res, 13, 839, 10.1158/1078-0432.CCR-06-2164 Sinclair, 2000, BRCA1 and BRCA2 have a limited role in familial prostate cancer, Cancer Res, 60, 1371 Robinson, 2015, Integrative clinical genomics of advanced prostate cancer, Cell, 161, 1215, 10.1016/j.cell.2015.05.001 Pritchard, 2016, Inherited DNA repair gene mutations in men with metastatic prostate cancer, N Engl J Med, 375, 443, 10.1056/NEJMoa1603144 Li, 2009, Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, 25, 1754, 10.1093/bioinformatics/btp324 Stenson, 2003, Human Gene Mutation Database (HGMD): 2003 update, Hum Mutat, 21, 577, 10.1002/humu.10212 Landrum, 2014, ClinVar: public archive of relationships among sequence variation and human phenotype, Nucleic Acids Res, 42, D980, 10.1093/nar/gkt1113 Green, 2013, ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, Genet Med, 15, 565, 10.1038/gim.2013.73 Carroll, 2016, Prostate cancer early detection, featured updates to the NCCN Guidelines, Version 2.2016, J Natl Compr Cancer Netw, 14, 509, 10.6004/jnccn.2016.0060 Kirchhoff, 2004, BRCA mutations and risk of prostate cancer in Ashkenazi Jews, Clin Cancer Res, 10, 2918, 10.1158/1078-0432.CCR-03-0604 Struewing, 1997, The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews, N Engl J Med, 336, 1401, 10.1056/NEJM199705153362001